Evidence map›Paper›PMID 40213045›Full record

ArticleData in brief2025

MO-NanoDatabase: A metal-oxide nanostructured compound dataset composed of a huge number of metal-oxide nanocompounds, their global properties and 3D-structure.

Francesc Serratosa, Natàlia Segura-Alabart

Abstract read
In one paragraph

Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Francesc SerratosaUniversitat Rovira i Virgili, Tarragona, Catalonia, Spain.
Natàlia Segura-AlabartUniversitat Rovira i Virgili, Tarragona, Catalonia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents the first important recompilation of metal-oxide nanocompounds, which is composed of three main parts: the first one includes several global properties of the nanocompounds whereas the second one includes their 3D structure, represented by the well-known XYZ format. Finally, the third part includes the structural nano QSAR named NanoFingerprint of these 3D structures. Modelling size-realistic metal-oxide nanomaterials to analyse some of their properties, such as chemical activity, solubility, or electronic structure, is a current challenge in computational and theoretical chemistry. Several nano QSAR models have been published based on global properties of these compounds, but few QSAR models also leverage their 3D structure. A general database of nanocompounds is crucial for the validation of current and future models. The global properties have been extracted from datasets published as the supporting material of papers that present new models for property prediction of metal-oxide nanocompounds [2-7]. The data has been curated, imposed the same units, formatted and given the same name per property since we realised the low generalisation on units, formats and nomenclature. Note the input parameters of the QSAR models and also the properties to be predicted have been put together as global properties in our database. Moreover, the 3D crystallographic structure has been computed through simulation computer applications of all the compounds since these structures could not be found in most of the cases. Since it is the first time that all this knowledge is compiled in a unique database, the purpose of MO-NanoDatabase is to be a reference database for prediction (chemical activity, solubility or electronic structure) of metal-oxide nanocompounds for current and future nano QSART models. Although many nanocompounds have been included, new versions of the database are not discarded if they bring substantial quantity of new nanocompounds presented in future papers.

Indexed as

3D structureChemical activityMetal-oxide nanocompoundToxicity predictionXYZ format

Identifiers

PMID40213045
PMCPMC11985051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.